Epigenetic abnormalities and therapies for hematological malignancies

被引：0
|
作者：
Toshio Kitamura
机构：
[1] University of Tokyo,Institute of Medical Science
来源：
International Journal of Hematology | 2019年 / 110卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 149
页数：2
相关论文
共 50 条
  • [41] Risk of Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies
    Andreescu, Mihaela
    LIFE-BASEL, 2023, 13 (06):
  • [42] Extramedullary disease and targeted therapies for hematological malignancies - is the association real?
    Raanani, P.
    Shpilberg, O.
    Ben-Bassat, I.
    ANNALS OF ONCOLOGY, 2007, 18 (01) : 7 - 12
  • [43] Secondary Dysgammaglobulinemia in Children with Hematological Malignancies Treated with Targeted Therapies
    Athanasios Tragiannidis
    Andreas H. Groll
    Pediatric Drugs, 2021, 23 : 445 - 455
  • [44] New 9P24 abnormalities in hematological malignancies
    Van Roosbroecki, K.
    Lahortigaz, I.
    Vandenberghe, P.
    De Wolf-Peeters, C.
    Bosly, A.
    Cools, J.
    Michaux, P.
    Wlodarska, I.
    ACTA CLINICA BELGICA, 2007, 62 (04): : 260 - 260
  • [45] A group of previously not recognized cytogenetic abnormalities in myeloid hematological malignancies
    Chen, Z
    Richkind, K
    Roherty, S
    Velasco, J
    Lytle, C
    Brothman, AR
    Sandberg, AA
    CANCER GENETICS AND CYTOGENETICS, 1999, 113 (02) : 162 - 165
  • [46] Endogenous retroelements in hematological malignancies: From epigenetic dysregulation to therapeutic targeting
    Chour, Mohamed
    Porteu, Francoise
    Depil, Stephane
    Alcazer, Vincent
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (01) : 116 - 130
  • [47] RNA methylation in hematological malignancies and its interactions with other epigenetic modifications
    Yao, Lan
    Yin, Hua
    Hong, Mei
    Wang, Yajun
    Yu, Tingting
    Teng, Yao
    Li, Tingting
    Wu, Qiuling
    LEUKEMIA, 2021, 35 (05) : 1243 - 1257
  • [48] RNA methylation in hematological malignancies and its interactions with other epigenetic modifications
    Lan Yao
    Hua Yin
    Mei Hong
    Yajun Wang
    Tingting Yu
    Yao Teng
    Tingting Li
    Qiuling Wu
    Leukemia, 2021, 35 : 1243 - 1257
  • [49] Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies
    Charles Craddock
    Clinical Epigenetics, 2013, 5 (Suppl 1)
  • [50] Risk of infection associated with targeted therapies for solid organ and hematological malignancies
    Ruiz-Camps, Isabel
    Aguilar-Company, Juan
    THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
12345